Carregant...
Alzheimer's disease drug development pipeline: 2018
INTRODUCTION: Treatments for Alzheimer's disease (AD) are needed due to the growing number of individuals with preclinical, prodromal, and dementia forms of AD. Drug development for AD therapies can be examined by inspecting the drug development pipeline as represented on clinicaltrials.gov. ME...
Guardat en:
| Publicat a: | Alzheimers Dement (N Y) |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6021548/ https://ncbi.nlm.nih.gov/pubmed/29955663 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2018.03.009 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|